An Intuition, Confirmed by Data from 41,000 People
🎧 ▶️ Press the play button below to listen.
Introduction: The “Free Pass” Trap
If you know someone who’s started taking a statin, a blood pressure pill, or metformin, you may have heard something like this: “I’m on medication now, so it’s fine if I have a steak every once in a while.”
That mindset has a name. It’s called risk compensation.
Risk compensation is a well-documented pattern in human behavior: when people feel protected by one intervention—a seatbelt, a vaccine, a medication—they tend to let their guard down in other areas.
The protection creates a psychological sense of safety, and that sense of safety subtly reshapes daily decisions. Sometimes those decisions are conscious (“I can skip the gym today; I’m on a statin”). Sometimes they’re not.
The problem is that risk compensation can quietly cancel out much of the benefit you’re hoping to gain. If a pill lowers your blood pressure by 10 points but you stop exercising and gain 15 pounds, you may end up no better off—or worse.
In 2020, Finnish researchers put hard numbers to this intuition. They tracked 41,225 public sector employees over age 40 who had no cardiovascular disease at baseline, comparing 8,837 people who newly started blood pressure or cholesterol medication with 46,021 who didn’t.
What they found was a paradox: people on medication became more likely to gain weight and stop exercising—but also more likely to quit smoking and drink less. Starting medication, it turns out, is a behavioral turning point that opens doors in both directions at once.
Why this matters even more if you have prediabetes or type 2 diabetes: For people managing blood sugar issues, the stakes of risk compensation are higher. Prediabetes and type 2 diabetes are conditions where lifestyle is not an optional add-on—it is the foundation of treatment.
Metformin and other glucose-lowering medications are powerful tools, but they work best when paired with movement, smart eating, and weight management. If starting a medication creates a false sense of security that leads to reduced physical activity, the result can be worsening blood sugar control, weight gain, and accelerated cardiovascular risk.
The very behavior that risk compensation discourages—regular exercise—is the same behavior that most directly improves insulin sensitivity and glucose control.
What this article will do: By the end, you’ll be able to recognize risk compensation in your own life—specifically, the moment you catch yourself thinking “the medication has me covered, so I can relax.”
That recognition is the first step to avoiding the trap. We’ll walk through what the Finnish study found, why the “free pass” mindset is so seductive, what the placebo-controlled evidence reveals about how much of this is really about the pill versus the psychology, and what you can do—as a patient or a clinician—to make sure medication adds to your health rather than subtracting from it.
Whether you’re on a statin, a blood pressure pill, metformin, or nothing at all, the same principle applies: the pill is a supplement, never a substitute.
The Study: What 41,000 People Revealed
The Finnish Public Sector Study followed its participants through surveys administered every four years from 2000 to 2013. Medication use was verified through pharmacy claims—not self-report—which makes the data unusually reliable. The comparison groups were large and well-matched.
The results were split, and both halves matter.
The Bad News: Weight Up, Exercise Down—and the Ozempic Twist
People who started medication had a significantly greater increase in BMI than those who didn’t (difference in change: 0.19; 95% CI 0.16–0.22). Their odds of becoming obese were 82% higher. Their physical activity also declined more, and their odds of becoming physically inactive were 8% higher.
At the individual level, these numbers look small—a 0.19 difference in BMI change amounts to about 1 pound of extra weight for someone who is 5’7″. But at the population level, when millions of people worldwide start these medications, small individual effects add up to a substantial public health signal.
The Finnish findings aren’t an isolated case. A 2014 study published in JAMA Internal Medicine—the Osteoporotic Fractures in Men Study—tracked nearly 6,000 men over 65 and found that new statin users showed a significantly faster decline in physical activity scores than never-users (an extra 0.9-point drop per year).
Accelerometer data were even more direct: statin users logged 5.4 fewer minutes of moderate-intensity activity per day and 7.6 more minutes of sedentary time than non-users.
For someone with prediabetes or type 2 diabetes, this decline in activity is particularly concerning. Skeletal muscle is the largest site of glucose disposal in the body, and muscle contractions during exercise increase glucose uptake through insulin-independent pathways.
When physical activity drops, you lose one of the most powerful tools for managing blood sugar—and the weight gain that often follows worsens insulin resistance.
The Good News: Quitting Smoking and Drinking Less
But if that were the whole story, it would just be a simple narrative about “medication makes people lazy.” The other side of the Finnish study was completely unexpected.
People on medication were significantly more likely to quit smoking. In the second survey, the odds ratio for current smoking in the medication group was 0.74 (95% CI 0.64–0.85)—meaning they were about 26% less likely than non-initiators to still be smoking. Their average weekly alcohol consumption also dropped by 1.85 grams (95% CI −3.67 to −0.14).
Why this split—backward on one front, forward on another?
One reasonable explanation is increased contact with the healthcare system. Starting a blood pressure pill or a statin means more frequent visits with doctors and nurses. In those visits, smoking cessation and alcohol reduction tend to be emphasized repeatedly, while weight management and exercise counseling are relatively weak.
In other words, what patients get asked about in the exam room is more often “Are you still smoking?” and “How much are you drinking?”—not “How many times a week are you exercising?”
That gap in counseling may be exactly where risk compensation takes root. And for patients with prediabetes or type 2 diabetes, the counseling gap around exercise and weight is especially consequential—because those are the very behaviors that most directly determine long-term outcomes.
Why Medication Triggers Risk Compensation
In the context of blood pressure pills, statins, and glucose-lowering medications like metformin, risk compensation works through several key elements:
Visibility: Taking medication is a daily, conscious act. It constantly reminds users, “I’m being protected.”
Perceived effectiveness: Patients believe the medication is handling their condition, and that belief itself changes their behavioral calculus.
Motivation: Taking medication means admitting you have a health problem, which can motivate behavior change—but that motivation can be misdirected into the belief that “the medication is already handling the problem.”
Sense of control: Having a prescription makes people feel they have control over their health. That sense of control can produce a psychological satisfaction of “I’ve already done what I needed to do,” reducing investment in other behaviors.
Simply put, risk compensation happens when people understand medication as “the solution” rather than “a supplement.”
For someone with prediabetes, this dynamic is particularly dangerous. The diagnosis itself is a wake-up call—a chance to reverse course before diabetes develops. But if metformin or another medication is prescribed, the patient may feel the problem is “handled” and miss the window when lifestyle changes could have the greatest impact.
For someone with type 2 diabetes, the same dynamic can lead to gradual weight gain, declining fitness, worsening blood sugar, and ultimately more medications—a cycle that could have been slowed or stopped with sustained lifestyle effort.
A Key Counterpoint: Placebo Also Makes People Less Active
When discussing whether medications directly cause reduced physical activity, one randomized controlled trial offers a crucial perspective.
A 2016 study by Panza and colleagues randomly assigned 418 healthy adults who had never taken statins to either a statin group or a placebo group for six months. All participants wore accelerometers to measure activity.
The result: both groups increased their sedentary time and decreased their physical activity—with no significant difference between the statin and placebo groups.
In other words, participating in a study, being measured regularly, and being told you’re taking a medication are themselves associated with declining activity. This suggests that at least part of the exercise decline observed in the Finnish study may not be a pharmacological effect of statins, but rather a consequence of the psychological and social meaning attached to “starting medication.”
This further supports the risk compensation explanation: what matters isn’t what’s inside the pill, but how the fact of “I’m taking medication” changes a person’s psychological state and behavioral decisions.
For patients with prediabetes or type 2 diabetes, this is actually empowering news. It means the biggest threat isn’t the drug itself—it’s the mindset. And mindsets can be changed.
What This Means for Patients and Doctors
First, it must be stated clearly: this is an observational study and cannot prove causation. Weight gain may partly reflect normal age-related trends, and it may also be confounded by the fact that people with higher metabolic risk are more likely to be prescribed medication in the first place. The study authors’ sensitivity analyses did not change the conclusions after excluding diabetes and cardiovascular events, but other unmeasured confounders may still exist.
Second, medication saves lives and prevents complications. The benefits of statins, antihypertensives, and glucose-lowering medications in reducing heart attacks, strokes, kidney disease, and cardiovascular death far outweigh the behavioral changes discussed here. No one should stop their medication because of this study.
But the study does deliver a clear clinical message: starting preventive medication is a teachable moment that needs to be used well.
For patients:
- If you start a statin, blood pressure medication, or metformin, deliberately maintain or even increase your exercise routine. Think of the medication as “adding one thing,” not “swapping one thing.”
- Watch your weight in the months after starting medication. If it starts creeping up, addressing it early is far easier than losing weight later.
- Use the increased healthcare contact to proactively ask your doctor or nurse for specific diet and exercise advice—don’t let the conversation stop at medication adjustments.
- Watch out for the risk compensation trap. If you notice yourself thinking “I’m on medication now, so I don’t need to work out today” or “the pill has me covered, so I can go ahead and indulge,” pause and recognize: this is risk compensation at work.
For patients with prediabetes or type 2 diabetes specifically:
- Exercise is not optional—it’s one of your most powerful glucose-lowering tools. A single session of moderate exercise can improve insulin sensitivity for up to 48 hours. When you skip workouts, your blood sugar control suffers, regardless of what medication you’re taking.
- Weight loss, when needed, has a dose-dependent effect on diabetes remission and reversal of prediabetes. Even a 5–7% reduction in body weight can significantly improve blood sugar control and, in prediabetes, cut the risk of progression to type 2 diabetes by more than half.
- Metformin is not a license to eat freely. It works best in combination with the same lifestyle habits that prevent diabetes in the first place. Think of it as a bridge, not a destination.
For clinicians:
- When prescribing, explicitly discuss weight management and physical activity, just as you would smoking cessation and alcohol reduction. Research shows the latter come up more often in the exam room, while the former are often overlooked.
- Consider using motivational interviewing and shared decision-making to help patients understand that medication and lifestyle are complementary, not interchangeable.
- Actively identify risk compensation signals during prescribing conversations. When a patient says “with this pill, I won’t have to work as hard,” that’s a teachable moment that needs an immediate response.
- For patients with prediabetes or type 2 diabetes, emphasize that exercise and weight management are not adjuncts to medication—they are core treatments. Frame medication as a tool that works best when lifestyle is optimized, not as a replacement for lifestyle effort.
The Bottom Line
Perhaps the most profound finding of this 41,000-person Finnish study isn’t a simple conclusion like “medication makes people lazy.” It’s this: starting medication is a behavioral turning point that opens doors in both directions at once.
The improvements in smoking and drinking are real and worth acknowledging. The risks of weight gain and reduced exercise are equally real. The difference is that the former get more attention and reinforcement in the exam room, while the latter are often assumed to be “handled by the medication.”
For people with prediabetes or type 2 diabetes, the stakes of this dynamic are even higher. These are conditions where lifestyle is not a supplement to treatment—it is the treatment. Medication can help, but it cannot replace the glucose-lowering effects of muscle contraction, the insulin-sensitizing benefits of regular exercise, or the metabolic improvements that come with weight loss.
When risk compensation leads to reduced activity and weight gain, the result is not just a missed opportunity—it’s a direct path to worsening blood sugar, more medications, and higher cardiovascular risk.
Risk compensation isn’t a moral failing—it’s the default setting of human cognition. When we feel protected, letting our guard down is a natural response. But becoming aware of that default setting is the first step to overriding it.
What medication can do is lower the risk you’ve already accumulated and help manage the condition you have. What it can’t do is build new healthy habits for you—or reverse the underlying metabolic dysfunction that drives prediabetes and type 2 diabetes. That work belongs to you, and it starts with recognizing the moment you’re tempted to hand it over to a pill.
And that gap—between what the pill can and can’t do—is exactly the space where patients and doctors can work together.
Don’t Get Sick!
About Dr. Jesse Santiano, MD
Dr. Santiano is a retired internist and emergency physician with extensive clinical experience in metabolic health, cardiovascular prevention, and lifestyle medicine. He reviews all medical content on this site to ensure accuracy, clarity, and safe application for readers. This article is for educational purposes and is not a substitute for personal medical care.
💡 Support This Work
Creating well-researched articles, maintaining this website, and keeping the information free takes time and resources.
If you found this article helpful, please consider donating to support the mission of empowering people to live healthier, longer lives, without relying on medications.
🙏 Every contribution, big or small, truly makes a difference. Thank you for your support!
Follow me on Facebook, Gab, Twitter (formerly known as X), Instagram, and Telegram.
Related:
- Depression And Cardiovascular Risk: Calculate Your AIP Score Now
- 15 Diseases Predicted By The Atherogenic Index Of Plasma
- How to Use AIP in Prediabetes and Type 2 Diabetes to Prevent Major Heart Events
- Your Angiogram Was ‘Fine’—So Why The Heart Attack? The AIP Clue In MINOCA
- Low LDL But Heart Attack Risk: Check AIP Now
- AIP Predicts Heart Attack Risk In Younger Adults
- AIP and Cardiovascular and Atherosclerotic Risk: A Simple TG/HDL Number That Tracks Artery Health
- Atherogenic Index (AIP): Meaning, Clinical Uses and Calculator
- Small Dense LDL: What It Means And How To Improve It
- ApoB vs LDL Cholesterol: Which Predicts Heart Attacks Better
- LDL Particle Number Explained: A Better Marker Than LDL Cholesterol
- TG/HDL Ratio Explained: What It Means and How to Improve It
- HDL Function Explained: Good vs Bad HDL
- High Triglycerides: Causes, Dangers, And How To Lower
- Metabolic Health Check: Your Metabolic Digest (What It Means + How to Improve It)
- New Science Debunks the Dangers of Saturated Fats on Heart Disease
References:
- Korhonen, M. J., Pentti, J., Hartikainen, J., Ilomäki, J., Setoguchi, S., Liew, D., Kivimäki, M., & Vahtera, J. (2020). Lifestyle changes in relation to initiation of antihypertensive and lipid-lowering medication: A cohort study. Journal of the American Heart Association, 9(4), e014168. https://doi.org/10.1161/JAHA.119.014168
- Lee, D. S., Markwardt, S., Goeres, L., Lee, C. G., Eckstrom, E., Williams, C., Fu, R., Orwoll, E., Cawthon, P. M., Stefanick, M. L., Mackey, D., Bauer, D. C., & Nielson, C. M. (2014). Statins and physical activity in older men: The Osteoporotic Fractures in Men Study. JAMA Internal Medicine, 174(8), 1263–1270. https://doi.org/10.1001/jamainternmed.2014.2266
- Panza, G. A., Taylor, B. A., Thompson, P. D., Dillingham, B. L., & White, C. M. (2016). The effect of atorvastatin on habitual physical activity among healthy adults. Medicine & Science in Sports & Exercise, 48(1), 1–6. https://doi.org/10.1249/MSS.0000000000000740
- Sugiyama, T., Tsugawa, Y., Tseng, C.-H., Kobayashi, Y., & Shapiro, M. F. (2014). Different time trends of caloric and fat intake between statin users and nonusers among US adults: Gluttony in the time of statins? JAMA Internal Medicine, 174(7), 1038–1045. https://doi.org/10.1001/jamainternmed.2014.1927
Disclaimer:
This article is for educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician before making health decisions based on the TyG Index or other biomarkers.
© 2018 – 2026 Asclepiades Medicine, LLC. All Rights Reserved
DrJesseSantiano.com does not provide medical advice, diagnosis, or treatment
As an Amazon Associate, I earn from qualifying purchases
Discover more from Don't Get Sick!
Subscribe to get the latest posts sent to your email.